亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

[Fragility Fractures in Hemodialysis Patients. Frailty and fragility fractures among dialysis patients.]

医学 透析 骨质疏松症 糖尿病 骨软化症 血液透析 内科学 人口 肌萎缩 外科 内分泌学 环境卫生
作者
Kenichi Akiyama,Norio Hanafusa
出处
期刊:PubMed [National Institutes of Health]
卷期号:28 (8): 1065-1073
链接
标识
摘要

According to the current status of chronic dialysis therapy in Japan 2016, the average age at the time of dialysis initiation is 68.57 years for males and 71.19 years for females, which has been rising continuously. Frailty is a geriatric syndrome that is frequently seen in the elderly. It is known that frailty among dialysis patients are more common than the general population of the same age, and that frailty is associated with life prognosis. As eGFR decreases, BMD decreases and fracture risk increase, and dialysis patients are at the highest risk of fracture in CKD patients. Various factors such as frailty, sarcopenia, PEW(protein-energy wasting), dynapenia, uremic osteoporosis, diabetes, AGEs(advanced glycation end products), oxidative stress, falls are involved in the increased risk of fracture in dialysis patients, and consequently, fragile fractures occur frequently in dialysis patients. Fragile fracture is a common complication in dialysis patients, and it is reported that the hospitalization for fracture, and the subsequent course is associated with poor prognosis. In diabetes, bone quality declines without loss of BMD, so the conventional DXA method may be insufficient in predicting fracture risk among dialysis patients, and the evaluation method using HR-pQCT or FRAXR may be useful. It has been reported that bisphosphonate is an established therapy in patients with primary osteoporosis, but many bisphosphonates cannot be used at eGFR of less than 30 mL/min per 1.73 m2. Bisphosphonate-related adverse effects such as accumulation, ossification, osteomalacia, ADB(adynamic bone), and jaw bone necrosis were reported, there are few reports of usefulness in CKD patients. Denosumab administration trial results for women with osteoporosis in dialysis patients have been waited(NCT 01464931). In this article, we outline the relation, diagnosis, and treatment of fragile fractures and frailty in dialysis patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
木十四完成签到 ,获得积分10
1秒前
2秒前
2秒前
zxc完成签到,获得积分10
4秒前
木木木木发布了新的文献求助10
8秒前
8秒前
Mm发布了新的文献求助20
8秒前
硅基生物完成签到 ,获得积分10
8秒前
l芒果不盲发布了新的文献求助10
12秒前
allover完成签到,获得积分10
13秒前
DONG完成签到,获得积分10
18秒前
Mm完成签到,获得积分10
21秒前
董庆山完成签到 ,获得积分10
21秒前
英姑应助木木木木采纳,获得10
28秒前
Sissy完成签到,获得积分10
28秒前
AliEmbark完成签到,获得积分10
31秒前
lanrui完成签到 ,获得积分10
32秒前
熊大发布了新的文献求助30
32秒前
小韩完成签到,获得积分10
32秒前
远望完成签到 ,获得积分10
35秒前
科研通AI6.2应助Sorexking采纳,获得10
42秒前
JEREMIAH完成签到,获得积分10
45秒前
瘦瘦的宛菡完成签到,获得积分10
48秒前
48秒前
科研通AI6.4应助Sorexking采纳,获得10
52秒前
木木木木发布了新的文献求助10
52秒前
53秒前
田様应助科研通管家采纳,获得10
54秒前
凶狠的翅膀完成签到,获得积分10
54秒前
54秒前
55秒前
57秒前
从容山槐发布了新的文献求助30
1分钟前
科研通AI6.2应助Sorexking采纳,获得10
1分钟前
科研通AI6.4应助Sorexking采纳,获得10
1分钟前
1分钟前
科研通AI6.4应助大海采纳,获得10
1分钟前
Hajimimimi发布了新的文献求助10
1分钟前
Ruby于完成签到,获得积分10
1分钟前
李林鑫完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
An Introduction to Foreign Language Learning and Teaching 750
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Governing Growth: Us Industrial Policy from Hamilton to Trump 500
The fast track to determining transfer functions of linear circuits: The student guide 500
The Analytical and Numerical Solution of Electric and Magnetic Fields 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7626237
求助须知:如何正确求助?哪些是违规求助? 9201027
关于积分的说明 19727594
捐赠科研通 7196959
什么是DOI,文献DOI怎么找? 3273785
关于科研通互助平台的介绍 2435949
邀请新用户注册赠送积分活动 2269751